Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.1.5ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
EG.1.5ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
EG.1.5ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
EG.1.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
EG.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.1.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EG.1.5SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
EG.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EG.1.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.5NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EG.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EG.1.5NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EG.1.5ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
XBB.8ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XBB.8ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XBB.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.8ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.8ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
XBB.8ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XBB.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.8SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBB.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.8NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBB.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.8NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.8ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-17590Japan
XAY.2.3ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XAY.2.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XAY.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAY.2.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XAY.2.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XAY.2.3ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
XAY.2.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used